On Monday 2 March, the Personalised Medicine and Resource Allocation Conference will take place at St Anne's College in Oxford.
The integration of genomic knowledge into health care could enable increasingly personalised medicine with improved health outcomes for patients.
Recent years have seen a rapid advancement of new genomic technologies. However, these technologies have not been translated on a large scale from research settings into routine clinical practice. This is partly due to a lack of high-quality translational research evidence on the ethical, legal, social and health economic implications of moving towards the integration of genomics in healthcare. One area which remains under-examined is how and through what processes healthcare resources should be allocated to enable the implementation of personalised medicine.
This conference brings together an international audience including health economists, health policy makers, ethicists and public health experts. Together we aim to explore ways to overcome the challenges facing the implementation of these technologies into widespread clinical practice with particular focus on the generation of economic evidence and the ethical issues underlying the resource allocation decisions that need to be taken in order for personalised medicine to be realised.